Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.
Published April 16, 2014 · Recall initiated: March 25, 2014
Summary
FDA records drug Class III recall D-1226-2014, published April 16, 2014 and initiated March 25, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 237,850 ampoules; Lot: Lot: 221303A, 1OCT2014. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling; Missing label; ampoules are missing the immediate container label
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot: 221303A, 1OCT2014
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDAetomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDCApril 16, 2014
- FDARitalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: NovartisApril 16, 2014
Questions about this recall
Was Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL. recalled?
Yes. FDA published recall D-1226-2014 on April 16, 2014. Reported hazard: Labeling; Missing label; ampoules are missing the immediate container label
What should I do if I have this product?
Voluntary: Firm initiated · Letter